PharmVIP: A Web-Based Tool for Pharmacogenomic Variant Analysis and Interpretation.

Area of Science:

• Genomics
• Bioinformatics
• Pharmacogenomics

Background:

• Next-generation sequencing (NGS) is increasingly available for personal genomics, yet analysis tools for pharmacogenomics (PGx) are inadequate.
• Existing tools lack comprehensive functions on a simple, web-based platform and do not analyze human leukocyte antigen (HLA) genes for immune-mediated adverse drug reactions (IM-ADRs).

Purpose of the Study:

• To introduce PharmVIP, a novel web-based platform for comprehensive analysis and interpretation of PGx and HLA variants from NGS data.
• To provide an integrated workflow facilitating both discovery and clinical application of PGx.

Main Methods:

• PharmVIP integrates three modules: Pharmacogenes, HLA, and Guideline.
• The Pharmacogenes module prioritizes variants based on functional impact.
• The HLA module analyzes HLA genotypes for IM-ADR risks, and the Guideline module translates genotypic data into Clinical Pharmacogenetics Implementation Consortium (CPIC) recommendations.

Main Results:

• PharmVIP offers a one-stop solution for genome-wide variant analysis from NGS data.
• The tool provides detailed, customizable reports in both interactive web and exportable formats.
• It facilitates the analysis of pharmacogenes and HLA types, linking them to drug response and potential adverse reactions.

Conclusions:

• PharmVIP addresses the need for a comprehensive, user-friendly web-based platform for PGx analysis.
• This integrated NGS workflow supports the pharmacogenomics community in accelerating discovery and clinical implementation of personalized medicine.